FDA Inspection 756928 — Radpharm, Inc.

Radpharm, Inc. — FEI 3008410340

The FDA completed an inspection of Radpharm, Inc. on Nov 17, 2011 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 17, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.